MSD has received the EC approval for Keytruda along with paclitaxel, with or without bevacizumab, as a treatment for PD-L1-positive ovarian cancer.

Gilead acquired Arcellx to gain the development and marketing rights to anito-cel, for which GlobalData forecasts sales of ...

A lack of effective non-invasive ways to diagnose endometriosis contributes to delayed intervention and limits the potential for clinical development of therapeutics. Credit: H_Ko/Shutterstock.com.

Daiichi Sankyo has collaborated with Tempus AI to expedite the clinical development and differentiation of an ADC programme ...

As ADC pipelines expand rapidly, innovations in payload linker chemistry are becoming a key enabler of next-generation ...

Eli Lilly and Insilico Medicines' AI-centric collaboration further deepens relations between the two companies, which began ...

At the 2026 ACC Scientific Session in New Orleans, researchers presented a meta-analysis of three randomized trials (1,264 ...

While there are currently no approved perioperative treatments for liver cancer, multiple late-stage trials are evaluating ...

Biocytogen has entered a strategic partnership with Sihuan Pharmaceutical to advance new therapeutics across several disease areas.

Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.

Blackstone says this is the largest private life sciences fund ever raised, which will support innovation in pharma and medtech.

The US Food and Drug Administration (FDA) will convene a public hearing intended to obtain feedback on its Commissioner’s ...